199 related articles for article (PubMed ID: 21467264)
21. A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications.
Marotta M; Chen X; Inoshita A; Stephens R; Budd GT; Crowe JP; Lyons J; Kondratova A; Tubbs R; Tanaka H
Breast Cancer Res; 2012 Nov; 14(6):R150. PubMed ID: 23181561
[TBL] [Abstract][Full Text] [Related]
22. Genomic hotspots but few recurrent fusion genes in breast cancer.
Fimereli D; Fumagalli D; Brown D; Gacquer D; Rothé F; Salgado R; Larsimont D; Sotiriou C; Detours V
Genes Chromosomes Cancer; 2018 Jul; 57(7):331-338. PubMed ID: 29436103
[TBL] [Abstract][Full Text] [Related]
23. Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
Tang MH; Dahlgren M; Brueffer C; Tjitrowirjo T; Winter C; Chen Y; Olsson E; Wang K; Törngren T; Sjöström M; Grabau D; Bendahl PO; Rydén L; Niméus E; Saal LH; Borg Å; Gruvberger-Saal SK
Oncotarget; 2015 Nov; 6(35):37169-84. PubMed ID: 26439695
[TBL] [Abstract][Full Text] [Related]
24. Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.
Matissek KJ; Onozato ML; Sun S; Zheng Z; Schultz A; Lee J; Patel K; Jerevall PL; Saladi SV; Macleay A; Tavallai M; Badovinac-Crnjevic T; Barrios C; Beşe N; Chan A; Chavarri-Guerra Y; Debiasi M; Demirdögen E; Egeli Ü; Gökgöz S; Gomez H; Liedke P; Tasdelen I; Tolunay S; Werutsky G; St Louis J; Horick N; Finkelstein DM; Le LP; Bardia A; Goss PE; Sgroi DC; Iafrate AJ; Ellisen LW
Cancer Discov; 2018 Mar; 8(3):336-353. PubMed ID: 29242214
[TBL] [Abstract][Full Text] [Related]
25. SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq).
Johnson SH; Smadbeck JB; Smoley SA; Gaitatzes A; Murphy SJ; Harris FR; Drucker TM; Zenka RM; Pitel BA; Rowsey RA; Hoppman NL; Aypar U; Sukov WR; Jenkins RB; Feldman AL; Kearney HM; Vasmatzis G
Cancer Genet; 2018 Feb; 221():1-18. PubMed ID: 29405991
[TBL] [Abstract][Full Text] [Related]
26. Optical mapping reveals a higher level of genomic architecture of chained fusions in cancer.
Chan EKF; Cameron DL; Petersen DC; Lyons RJ; Baldi BF; Papenfuss AT; Thomas DM; Hayes VM
Genome Res; 2018 May; 28(5):726-738. PubMed ID: 29618486
[TBL] [Abstract][Full Text] [Related]
27. RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas.
Blum AE; Venkitachalam S; Guo Y; Kieber-Emmons AM; Ravi L; Chandar AK; Iyer PG; Canto MI; Wang JS; Shaheen NJ; Barnholtz-Sloan JS; Markowitz SD; Willis JE; Shyr Y; Chak A; Varadan V; Guda K
Cancer Res; 2016 Oct; 76(19):5628-5633. PubMed ID: 27503924
[TBL] [Abstract][Full Text] [Related]
28. Identification of fusion genes in breast cancer by paired-end RNA-sequencing.
Edgren H; Murumagi A; Kangaspeska S; Nicorici D; Hongisto V; Kleivi K; Rye IH; Nyberg S; Wolf M; Borresen-Dale AL; Kallioniemi O
Genome Biol; 2011; 12(1):R6. PubMed ID: 21247443
[TBL] [Abstract][Full Text] [Related]
29. Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes.
Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Ursule L; Nguyen C; Redon R; du Manoir S; Rodriguez C; Theillet C
Cancer Res; 2004 Sep; 64(18):6453-60. PubMed ID: 15374954
[TBL] [Abstract][Full Text] [Related]
30. Novel fusion transcripts in human gastric cancer revealed by transcriptome analysis.
Kim HP; Cho GA; Han SW; Shin JY; Jeong EG; Song SH; Lee WC; Lee KH; Bang D; Seo JS; Kim JI; Kim TY
Oncogene; 2014 Nov; 33(47):5434-41. PubMed ID: 24240688
[TBL] [Abstract][Full Text] [Related]
31. A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome.
Hampton OA; Den Hollander P; Miller CA; Delgado DA; Li J; Coarfa C; Harris RA; Richards S; Scherer SE; Muzny DM; Gibbs RA; Lee AV; Milosavljevic A
Genome Res; 2009 Feb; 19(2):167-77. PubMed ID: 19056696
[TBL] [Abstract][Full Text] [Related]
32. Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.
Hartmaier RJ; Trabucco SE; Priedigkeit N; Chung JH; Parachoniak CA; Vanden Borre P; Morley S; Rosenzweig M; Gay LM; Goldberg ME; Suh J; Ali SM; Ross J; Leyland-Jones B; Young B; Williams C; Park B; Tsai M; Haley B; Peguero J; Callahan RD; Sachelarie I; Cho J; Atkinson JM; Bahreini A; Nagle AM; Puhalla SL; Watters RJ; Erdogan-Yildirim Z; Cao L; Oesterreich S; Mathew A; Lucas PC; Davidson NE; Brufsky AM; Frampton GM; Stephens PJ; Chmielecki J; Lee AV
Ann Oncol; 2018 Apr; 29(4):872-880. PubMed ID: 29360925
[TBL] [Abstract][Full Text] [Related]
33. Second generation sequencing of the mesothelioma tumor genome.
Bueno R; De Rienzo A; Dong L; Gordon GJ; Hercus CF; Richards WG; Jensen RV; Anwar A; Maulik G; Chirieac LR; Ho KF; Taillon BE; Turcotte CL; Hercus RG; Gullans SR; Sugarbaker DJ
PLoS One; 2010 May; 5(5):e10612. PubMed ID: 20485525
[TBL] [Abstract][Full Text] [Related]
34. Next generation mapping reveals novel large genomic rearrangements in prostate cancer.
Jaratlerdsiri W; Chan EKF; Petersen DC; Yang C; Croucher PI; Bornman MSR; Sheth P; Hayes VM
Oncotarget; 2017 Apr; 8(14):23588-23602. PubMed ID: 28423598
[TBL] [Abstract][Full Text] [Related]
35. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing.
Guffanti A; Iacono M; Pelucchi P; Kim N; Soldà G; Croft LJ; Taft RJ; Rizzi E; Askarian-Amiri M; Bonnal RJ; Callari M; Mignone F; Pesole G; Bertalot G; Bernardi LR; Albertini A; Lee C; Mattick JS; Zucchi I; De Bellis G
BMC Genomics; 2009 Apr; 10():163. PubMed ID: 19379481
[TBL] [Abstract][Full Text] [Related]
36. High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer.
Amirfallah A; Arason A; Einarsson H; Gudmundsdottir ET; Freysteinsdottir ES; Olafsdottir KA; Johannsson OT; Agnarsson BA; Barkardottir RB; Reynisdottir I
PLoS One; 2019; 14(8):e0221413. PubMed ID: 31442252
[TBL] [Abstract][Full Text] [Related]
37. Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression.
Grinchuk OV; Motakis E; Kuznetsov VA
BMC Genomics; 2010 Feb; 11 Suppl 1(Suppl 1):S9. PubMed ID: 20158880
[TBL] [Abstract][Full Text] [Related]
38. Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications.
Veeraraghavan J; Ma J; Hu Y; Wang XS
Breast Cancer Res Treat; 2016 Jul; 158(2):219-32. PubMed ID: 27372070
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer.
Bashir A; Volik S; Collins C; Bafna V; Raphael BJ
PLoS Comput Biol; 2008 Apr; 4(4):e1000051. PubMed ID: 18404202
[TBL] [Abstract][Full Text] [Related]
40. Nonrecurrent 17p11.2p12 Rearrangement Events that Result in Two Concomitant Genomic Disorders: The PMP22-RAI1 Contiguous Gene Duplication Syndrome.
Yuan B; Harel T; Gu S; Liu P; Burglen L; Chantot-Bastaraud S; Gelowani V; Beck CR; Carvalho CM; Cheung SW; Coe A; Malan V; Munnich A; Magoulas PL; Potocki L; Lupski JR
Am J Hum Genet; 2015 Nov; 97(5):691-707. PubMed ID: 26544804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
